Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 305

1.

Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.

Child CJ, Quigley CA, Cutler GB Jr, Moore WV, Wintergerst KA, Ross JL, Rosenfeld RG, Blum WF.

Horm Res Paediatr. 2019;91(4):241-251. doi: 10.1159/000500087. Epub 2019 Jun 11.

PMID:
31185471
2.

Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.

Winer KK, Kelly A, Johns A, Zhang B, Dowdy K, Kim L, Reynolds JC, Albert PS, Cutler GB Jr.

J Pediatr. 2018 Dec;203:391-399.e1. doi: 10.1016/j.jpeds.2018.08.010.

PMID:
30470382
3.

Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes.

Blum WF, Klammt J, Amselem S, Pfäffle HM, Legendre M, Sobrier ML, Luton MP, Child CJ, Jones C, Zimmermann AG, Quigley CA, Cutler GB Jr, Deal CL, Lebl J, Rosenfeld RG, Parks JS, Pfäffle RW.

EBioMedicine. 2018 Oct;36:390-400. doi: 10.1016/j.ebiom.2018.09.026. Epub 2018 Sep 25. No abstract available.

4.

Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.

Leschek EW, Flor AC, Bryant JC, Jones JV, Barnes KM, Cutler GB Jr.

J Pediatr. 2017 Nov;190:229-235. doi: 10.1016/j.jpeds.2017.07.047.

5.

In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog.

Owens RA, Hansen RJ, Kahl SD, Zhang C, Ruan X, Koester A, Li S, Qian HR, Farmen MW, Michael MD, Moyers JS, Cutler GB Jr, Vick A, Beals JM.

J Pharmacol Exp Ther. 2016 Jun;357(3):459-65. doi: 10.1124/jpet.115.231035. Epub 2016 Mar 29.

PMID:
27026683
6.

Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes.

Child CJ, Blum WF, Deal C, Zimmermann AG, Quigley CA, Drop SL, Cutler GB Jr, Rosenfeld RG.

Eur J Endocrinol. 2016 May;174(5):669-79. doi: 10.1530/EJE-15-1203. Epub 2016 Feb 17.

PMID:
26888628
7.

Radiological Features in Patients with Short Stature Homeobox-Containing (SHOX) Gene Deficiency and Turner Syndrome before and after 2 Years of GH Treatment.

Child CJ, Kalifa G, Jones C, Ross JL, Rappold GA, Quigley CA, Zimmermann AG, Garding G, Cutler GB Jr, Blum WF.

Horm Res Paediatr. 2015;84(1):14-25. doi: 10.1159/000381712. Epub 2015 May 6.

PMID:
25967354
8.

Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism.

Winer KK, Fulton KA, Albert PS, Cutler GB Jr.

J Pediatr. 2014 Sep;165(3):556-63.e1. doi: 10.1016/j.jpeds.2014.04.060. Epub 2014 Jun 16.

9.
10.

Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency.

Blum WF, Deal C, Zimmermann AG, Shavrikova EP, Child CJ, Quigley CA, Drop SL, Cutler GB Jr, Rosenfeld RG.

Eur J Endocrinol. 2013 Nov 22;170(1):13-21. doi: 10.1530/EJE-13-0643. Print 2014 Jan.

PMID:
24088548
11.

GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.

Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G, Deal C, Drop SL, Rappold G, Cutler GB Jr.

J Clin Endocrinol Metab. 2013 Aug;98(8):E1383-92. doi: 10.1210/jc.2013-1222. Epub 2013 May 29. Erratum in: J Clin Endocrinol Metab. 2013 Dec;98(12):4992.

PMID:
23720786
12.

Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational study.

Deal C, Hasselmann C, Pfäffle RW, Zimmermann AG, Quigley CA, Child CJ, Shavrikova EP, Cutler GB Jr, Blum WF.

Horm Res Paediatr. 2013;79(5):283-92. doi: 10.1159/000350829. Epub 2013 May 16.

PMID:
23689058
13.

Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.

Hartman ML, Xu R, Crowe BJ, Robison LL, Erfurth EM, Kleinberg DL, Zimmermann AG, Woodmansee WW, Cutler GB Jr, Chipman JJ, Melmed S; International HypoCCS Advisory Board.

J Clin Endocrinol Metab. 2013 Mar;98(3):980-8. doi: 10.1210/jc.2012-2684. Epub 2013 Jan 23.

14.

Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.

Winer KK, Zhang B, Shrader JA, Peterson D, Smith M, Albert PS, Cutler GB Jr.

J Clin Endocrinol Metab. 2012 Feb;97(2):391-9. doi: 10.1210/jc.2011-1908. Epub 2011 Nov 16. Erratum in: J Clin Endocrinol Metab. 2015 Jul;100(7):2800.

15.

Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program.

Child CJ, Zimmermann AG, Scott RS, Cutler GB Jr, Battelino T, Blum WF; GeNeSIS International Advisory Board.

J Clin Endocrinol Metab. 2011 Jun;96(6):E1025-34. doi: 10.1210/jc.2010-3023. Epub 2011 Apr 13. Erratum in: J Clin Endocrinol Metab. 2011 Aug;96(8):2624.

PMID:
21490076
16.

Growth hormone plus childhood low-dose estrogen in Turner's syndrome.

Ross JL, Quigley CA, Cao D, Feuillan P, Kowal K, Chipman JJ, Cutler GB Jr.

N Engl J Med. 2011 Mar 31;364(13):1230-42. doi: 10.1056/NEJMoa1005669.

17.

Cortisol response to individualised graded insulin infusions: a reproducible biomarker for CNS compounds inhibiting HPA activation.

Chen CL, Willis BA, Mooney L, Ong GK, Lim CN, Lowe SL, Tauscher-Wisniewski S, Cutler GB Jr, Wiss SD.

Br J Clin Pharmacol. 2010 Dec;70(6):886-94. doi: 10.1111/j.1365-2125.2010.03781.x.

18.

Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.

Zeger MP, Shah K, Kowal K, Cutler GB Jr, Kushner H, Ross JL.

Horm Res Paediatr. 2011;75(1):38-46. doi: 10.1159/000317529. Epub 2010 Aug 20.

PMID:
20733274
19.

Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.

Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr.

J Clin Endocrinol Metab. 2010 Jun;95(6):2680-8. doi: 10.1210/jc.2009-2464. Epub 2010 Apr 14.

20.

Does availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 diabetes?

Bergenstal RM, Freemantle N, Leyk M, Cutler GB Jr, Hayes RP, Muchmore DB.

Diabetes Technol Ther. 2009 Sep;11 Suppl 2:S45-52. doi: 10.1089/dia.2009.0028.

PMID:
19772448
21.

Effects of treatment with oxandrolone for 4 years on the frequency of severe arithmetic learning disability in girls with Turner syndrome.

Ross JL, Mazzocco MM, Kushner H, Kowal K, Cutler GB Jr, Roeltgen D.

J Pediatr. 2009 Nov;155(5):714-20. doi: 10.1016/j.jpeds.2009.05.031. Epub 2009 Jul 29.

PMID:
19643440
22.

Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.

Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr.

J Clin Endocrinol Metab. 2008 Sep;93(9):3389-95. doi: 10.1210/jc.2007-2552. Epub 2008 May 20.

23.

Effect of growth hormone dose on bone maturation and puberty in children with idiopathic short stature.

Crowe BJ, Rekers-Mombarg LT, Robling K, Wolka AM, Cutler GB Jr, Wit JM; European Idiopathic Short Stature Group.

J Clin Endocrinol Metab. 2006 Jan;91(1):169-75. Epub 2005 Nov 1.

PMID:
16263828
24.

The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome.

Ross JL, Kowal K, Quigley CA, Blum WF, Cutler GB Jr, Crowe B, Hovanes K, Elder FF, Zinn AR.

J Pediatr. 2005 Oct;147(4):499-507.

PMID:
16227037
25.

Identification of a major recombination hotspot in patients with short stature and SHOX deficiency.

Schneider KU, Sabherwal N, Jantz K, Röth R, Muncke N, Blum WF, Cutler GB Jr, Rappold G.

Am J Hum Genet. 2005 Jul;77(1):89-96. Epub 2005 Jun 1.

26.

Safety of growth hormone treatment in pediatric patients with idiopathic short stature.

Quigley CA, Gill AM, Crowe BJ, Robling K, Chipman JJ, Rose SR, Ross JL, Cassorla FG, Wolka AM, Wit JM, Rekers-Mombarg LT, Cutler GB Jr.

J Clin Endocrinol Metab. 2005 Sep;90(9):5188-96. Epub 2005 May 17.

PMID:
15899952
27.

Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.

Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.

J Pediatr. 2005 Jan;146(1):45-53.

PMID:
15644821
28.

Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo.

Ross JL, Sandberg DE, Rose SR, Leschek EW, Baron J, Chipman JJ, Cassorla FG, Quigley CA, Crowe BJ, Roberts K, Cutler GB Jr.

J Clin Endocrinol Metab. 2004 Oct;89(10):4873-8.

PMID:
15472178
29.

Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial.

Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler GB Jr, Baron J; National Institute of Child Health and Human Development-Eli Lilly & Co. Growth Hormone Collaborative Group.

J Clin Endocrinol Metab. 2004 Jul;89(7):3140-8.

PMID:
15240584
30.

Treatment of hypopituitary children.

Cutler GB Jr, Chipman JJ.

J Pediatr. 2004 Apr;144(4):415-6. No abstract available.

PMID:
15069384
31.

Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report.

Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD; Interventions on Frailty Working Group.

J Am Geriatr Soc. 2004 Apr;52(4):625-34. Review.

PMID:
15066083
32.

In boys with abnormal developmental tempo, maturation of the skeleton and the hypothalamic-pituitary-gonadal axis remains synchronous.

Flor-Cisneros A, Leschek EW, Merke DP, Barnes KM, Coco M, Cutler GB Jr, Baron J.

J Clin Endocrinol Metab. 2004 Jan;89(1):236-41.

PMID:
14715856
33.

Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.

Weise M, Flor A, Barnes KM, Cutler GB Jr, Baron J.

J Clin Endocrinol Metab. 2004 Jan;89(1):103-7.

PMID:
14715835
34.

Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.

Nunez SB, Calis K, Cutler GB Jr, Jones J, Feuillan PP.

J Clin Endocrinol Metab. 2003 Dec;88(12):5730-3.

PMID:
14671160
35.

Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr.

J Clin Endocrinol Metab. 2003 Sep;88(9):4214-20.

PMID:
12970289
36.

Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.

Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, Cutler GB Jr.

N Engl J Med. 2003 Mar 6;348(10):908-17.

37.

Androgen-responsive aspects of cognition in girls with Turner syndrome.

Ross JL, Roeltgen D, Stefanatos GA, Feuillan P, Kushner H, Bondy C, Cutler GB Jr.

J Clin Endocrinol Metab. 2003 Jan;88(1):292-6.

PMID:
12519868
38.

Follow-up of children and young adults after GnRH-agonist therapy or central precocious puberty.

Feuillan PP, Jones JV, Barnes K, Klein KO, Cutler GB Jr.

J Endocrinol Invest. 2001 Oct;24(9):734-6. Review. No abstract available.

PMID:
11716160
39.

Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.

Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB Jr.

J Clin Endocrinol Metab. 2001 Oct;86(10):4711-6.

PMID:
11600530
40.

Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty.

Leschek EW, Chan WY, Diamond DA, Kaefer M, Jones J, Barnes KM, Cutler GB Jr.

J Pediatr. 2001 Jun;138(6):949-51.

PMID:
11391350
41.

New ideas for medical treatment of congenital adrenal hyperplasia.

Merke DP, Cutler GB Jr.

Endocrinol Metab Clin North Am. 2001 Mar;30(1):121-35. Review.

PMID:
11344931
42.

Evidence for decreased growth hormone in patients with hypothalamic hamartoma due to Pallister-Hall syndrome.

Feuillan P, Peters KF, Cutler GB Jr, Biesecker LG.

J Pediatr Endocrinol Metab. 2001 Feb;14(2):141-9.

PMID:
11305791
43.
44.

Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy.

Feuillan PP, Jones JV, Barnes KM, Oerter-Klein K, Cutler GB Jr.

J Clin Endocrinol Metab. 2000 Nov;85(11):4036-8.

PMID:
11095429
45.

Use of aromatase inhibitors in precocious puberty.

Feuillan P, Merke D, Leschek EW, Cutler GB Jr.

Endocr Relat Cancer. 1999 Jun;6(2):303-6. Review.

PMID:
10731123
46.
47.

Suppression and recovery of GH secretion after GH injection in non-GH deficient short children.

Rose SR, Baron J, Bernstein D, Yanovski J, Troendle JF, Leschek E, Chipman J, Cutler GB Jr.

J Pediatr Endocrinol Metab. 2000 Mar;13(3):281-8.

PMID:
10714753
49.

Carbenoxolone effects in congenital adrenal hyperplasia

Irony I I, Cutler GB.

Clin Endocrinol (Oxf). 2000 Feb;52(2):247-8. No abstract available.

PMID:
10671958
50.

Use of estrogen in young girls with Turner syndrome: effects on memory.

Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler GB Jr.

Neurology. 2000 Jan 11;54(1):164-70.

PMID:
10636143

Supplemental Content

Loading ...
Support Center